Viswanathan, Sowmya

Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature

Viswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K., Martin, I., Nolta, J., Phinney, D. G., & Sensebe, L. (2019) · Cytotherapy

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 839

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

Blanc, K. L., Dazzi, F., English, K., Farge, D., Galipeau, J., Horwitz, E. M., Kadri, N., Krampera, M., Lalu, M. M., Nolta, J., et al. (2025) · Cytotherapy

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 48

Current state of Health Canada regulation for cellular and gene therapy products: potential cures on the horizon

Chisholm, J., Ruff, C., & Viswanathan, S. (2019) · Cytotherapy

Biomedical Ethics and RegulationHealthcare Regulation

Cited by 27

Standards efforts and landscape for rapid microbial testing methodologies in regenerative medicine

Lin-Gibson, S., Lin, N. J., Jackson, S., Viswanathan, S., Zylberberg, C., Wolfrum, J., Basu, S., Roy, K., Marshall, D., McFarland, R., et al. (2021) · Cytotherapy

Biomedical Ethics and RegulationHealthcare Regulation

Cited by 12